Alembic Pharmaceuticals Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was INR 62,286.3 million compared to INR 56,526.2 million a year ago. Revenue was INR 62,569.3 million compared to INR 56,553.6 million a year ago.

Net income was INR 6,158.2 million compared to INR 3,419.9 million a year ago. Basic earnings per share from continuing operations was INR 31.33 compared to INR 17.4 a year ago. Diluted earnings per share from continuing operations was INR 31.33 compared to INR 17.4 a year ago.